Mercury Laboratories Ltd - Stock Valuation and Financial Performance

BSE: 538964 | NSE: | Pharmaceuticals & Drugs | Small Cap

Mercury Laboratories Share Price

972.90 -3.05 -0.31%
as on 03-Dec'24 16:59

DeciZen - make an informed investing decision on Mercury Laboratories

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Mercury Laboratories stock performance -

mw4me loader
P/E Ratio (SA):
29.36
Market Cap:
117.1 Cr.
52-wk low:
721.2
52-wk high:
1,303

Is Mercury Laboratories Ltd an attractive stock to invest in?

1. Is Mercury Laboratories Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Mercury Laboratories Ltd is a good quality company.

2. Is Mercury Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Mercury Laboratories Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Mercury Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Mercury Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Mercury Laboratories:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Mercury Laboratories Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 21.3%21.6%18.9%9.9%13.8%13.3%20.6%12.3%16.2%13.6%-
Value Creation
Index
0.50.50.4-0.30.0-0.10.5-0.10.20.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 41.247.54851.955.557.368.657.975.375.669
Sales YoY Gr.-15.4%1.1%8%7%3.2%19.8%-15.6%30.1%0.3%-
Adj EPS 26.830.323.616.820.726.242.926.339.344.133.2
YoY Gr.-13.2%-22.3%-28.7%23.2%26.5%63.6%-38.7%49.3%12.2%-
BVPS (₹) 151.2182.1203.9219.6241.4266.5307.5335.9380.2423.7430.8
Adj Net
Profit
3.23.62.822.53.15.13.24.75.34
Cash Flow from Ops. 3.5-0.11.955.25.58.25.22.58.2-
Debt/CF from Ops. 2.6-763.921.81.30.912.20.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 7%6.4%3.3%0.3%
Adj EPS 5.7%16.3%0.9%12.2%
BVPS12.1%11.9%11.3%11.4%
Share Price - 28.9% 19% 23.2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
19.218.212.27.9910.314.98.211117.8
Op. Profit
Mgn %
1413.614.48.510.310.81412.111.41211.2
Net Profit
Mgn %
7.87.75.93.94.55.57.55.56.375.8
Debt to
Equity
0.50.30.30.40.30.20.20.10.10.10.1
Working Cap
Days
17417721020119219617120115015597
Cash Conv.
Cycle
51547283727664878410065

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 7.80%

Sales growth has been subdued in last 3 years 3.27%

Net Profit has been subdued in last 3 years 0.92%

Sales growth is not so good in last 4 quarters at -8.54%

Latest Financials - Mercury Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 33.2 -
TTM Sales (₹ Cr.) 69.4 -
BVPS (₹.) 430.8 -
Reserves (₹ Cr.) 50 -
P/BV 2.27 -
PE 29.36 -
From the Market
52 Week Low / High (₹) 721.15 / 1303.00
All Time Low / High (₹) 32.49 / 1303.00
Market Cap (₹ Cr.) 117
Equity (₹ Cr.) 1.2
Face Value (₹) 10
Industry PE 44.7

Management X-Ray of Mercury Laboratories:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Mercury Laboratories

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales41484852565769587576
Operating Expenses 35414147505159516767
Manufacturing Costs89911111114111615
Material Costs11131416191721151920
Employee Cost 67778910121414
Other Costs 10121214121315121817
Operating Profit 66746610799
Operating Profit Margin (%) 14.0%13.6%14.0%8.4%10.3%10.8%14.0%12.1%11.4%12.0%
Other Income 1100111121
Interest 1111111000
Depreciation 1111222223
Exceptional Items 0000000000
Profit Before Tax 5552448577
Tax 1120113121
Profit After Tax 3432335466
PAT Margin (%) 8.0%8.3%5.6%3.9%5.1%5.6%7.8%6.1%7.4%7.5%
Adjusted EPS (₹)27.632.722.516.823.626.944.529.746.547.1
Dividend Payout Ratio (%)5%5%7%9%6%7%8%12%8%7%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 18222426293237404651
Share Capital 1111111111
Reserves 17212325283136394450
Minority Interest0000000000
Debt67710966555
Long Term Debt23710966223
Short Term Debt4400000332
Trade Payables7810912812765
Others Liabilities 111197810101077
Total Liabilities 43475152575665626468

Fixed Assets

Gross Block25252630353741434446
Accumulated Depreciation6789111315172022
Net Fixed Assets19191821242426262424
CWIP 0000000004
Investments 0000000000
Inventories4688765776
Trade Receivables12131815191823172122
Cash Equivalents 1114135778
Others Assets5764566644
Total Assets 43475152575665626468

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 3025558528
PBT 5552448577
Adjustment 2222333333
Changes in Working Capital -1-5-41-1-0-1-1-7-1
Tax Paid -1-1-1-1-1-1-1-2-1-1
Cash Flow From Investing Activity -20-2-4-5-1-5-2-1-6
Capex -20-2-4-5-1-5-2-1-6
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity -2001-3-3-1-1-1-1
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 00-12-1-20-100
Interest Paid 00-1-1-1-1-1000
Dividend Paid 0000000000
Others -211000010-1
Net Cash Flow 0002-212201
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)19.7519.6211.677.9210.2610.5915.59.2312.9811.72
ROCE (%)21.3221.5818.939.8913.7713.2520.5612.2616.1913.61
Asset Turnover Ratio1.041.131.031.021.021.011.130.911.191.14
PAT to CFO Conversion(x)100.672.51.671.671.61.250.331.33
Working Capital Days
Receivable Days1029311311211211910812492104
Inventory Days34395153483928383332
Payable Days229207240222200211178226128104

Mercury Laboratories Ltd Stock News

Mercury Laboratories Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Mercury Laboratories on 03-Dec-2024 16:59 is ₹972.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Dec-2024 16:59 the market cap of Mercury Laboratories stood at ₹117.1.
The latest P/E ratio of Mercury Laboratories as of 03-Dec-2024 16:59 is 29.36.
The latest P/B ratio of Mercury Laboratories as of 03-Dec-2024 16:59 is 2.27.
The 52-week high of Mercury Laboratories is ₹1,303 and the 52-week low is ₹721.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Mercury Laboratories is ₹69.35 ( Cr.) .

About Mercury Laboratories Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.